Purple Biotech Income Statement (2014-2026)

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Revenue & Cost
Revenue (Quarter)
Interest income
Interest Income - Debt Securities (Quarter)												-0.61M	-0.95M			-0.93M	-0.07M			-2.17M
Interest Income - Deposits (Quarter)	0.07M	0.18M	0.24M	0.13M	0.01M	0.18M		0.35M	0.20M	0.13M	0.08M	0.12M	0.08M	0.07M	0.04M	0.04M	0.05M	0.05M	0.05M	0.05M
Interest Income - Total (Quarter)	0.02M	-0.05M		-0.01M	-0.04M	-0.23M		-0.22M			0.88M	-0.69M			-0.60M	-0.95M			0.20M	-2.16M
Interest expenses
Interest Expenses (Quarter)	0.10M	0.02M	0.09M	0.04M	0.05M	0.02M	0.02M	0.06M	0.15M	0.02M	2.09M	0.02M	0.02M	0.51M	-0.07M	0.04M	0.03M	0.01M	0.21M	0.03M
Interest Income - Net (Quarter)	-0.08M	-0.07M		-0.06M	-0.09M	-0.25M		-0.28M			-1.21M	-0.70M			-0.53M	-0.98M			-0.02M	-2.19M
Non-interest income
Trading Income (Quarter)	3.64M	3.15M	8.26M	7.32M	3.57M	4.85M	6.04M	4.90M	5.16M	5.05M	4.86M	3.80M	2.42M	0.67M	0.41M	0.46M	1.09M	1.30M	23.64M	0.09M
Other Non-Interest Income (Quarter)
Non-Interest Income (Quarter)	3.64M	3.15M	8.26M	7.32M	3.57M	4.85M	6.04M	4.90M	5.16M	5.05M	4.86M	3.80M	2.42M	0.67M	0.41M	0.46M	1.09M	1.30M	23.64M	0.09M
Operating Items
Research & Development (Quarter)	2.09M	1.62M	4.87M	5.95M	2.08M	3.46M	4.82M	3.50M	3.71M	4.59M	5.24M	3.42M	2.39M	1.35M	0.46M	0.76M	0.55M	0.59M	1.83M	1.23M
Selling, General & Administrative (Quarter)	1.53M	1.42M	2.91M	1.38M	1.51M	1.62M	1.78M	1.62M	1.43M	1.16M	1.02M	1.04M	0.86M	0.79M	0.56M	0.65M	0.68M	0.78M	1.14M	1.02M
Restructuring Costs (Quarter)
Other Operating Expenses (Quarter)		0.15M
Operating Expenses (Quarter)	3.62M	3.20M	7.78M	7.33M	3.59M	5.08M	6.60M	5.12M	5.13M	5.75M	6.27M	4.47M	3.26M	2.13M	1.02M	1.41M	1.24M	1.37M	2.96M	2.25M
Operating Income (Quarter)	3.62M	3.04M	7.78M	7.33M	3.59M	5.08M	6.60M	5.12M	5.13M	5.75M	6.27M	4.47M	3.46M	2.13M	1.02M	1.41M	1.24M	1.37M	23.45M	2.25M
EBIT (Quarter)	3.62M	3.04M	7.78M	7.33M	3.59M	5.08M	6.60M	5.12M	5.13M	5.75M	6.27M	4.47M	3.46M	2.13M	1.02M	1.41M	1.24M	1.37M	23.45M	2.25M
Non-operating items
Non Operating Investment Income (Quarter)											-3.50M		-0.95M	-1.85M	-0.08M				0.06M
Interest & Investment Income (Quarter)	-0.08M	-0.07M	-0.12M	-0.06M	-0.09M	-0.25M	-0.58M	-0.28M	-0.12M	-0.71M	-1.41M	-0.10M	-0.12M	-0.13M	-0.46M	-0.05M	-0.07M	-0.12M	-0.08M	-0.02M
Other Non Operating Income (Quarter)			0.01M				-0.56M				-3.50M
Non Operating Income (Quarter)	0.02M	-0.05M	-0.03M	-0.01M	-0.04M			-0.22M	0.03M	-0.69M	-1.41M	-0.69M	-0.97M	-1.47M	-0.60M	-0.95M	-0.15M	-0.06M	0.20M	-2.16M
Net income details
EBT (Quarter)	3.44M	2.95M	7.57M	7.23M	3.45M	4.82M	6.01M	4.79M	4.86M	5.02M	2.77M	4.35M	3.31M	1.49M	0.63M	1.32M	1.14M	1.24M	23.15M	2.20M
Profit After Tax (Quarter)	3.64M	3.15M	7.75M	7.32M	3.55M	4.85M	6.04M	4.79M	4.86M	5.02M	-4.86M	4.35M	3.31M	1.49M	0.63M	1.32M	1.14M	1.24M	23.15M	2.20M
Income from Non-Controlling Interests (Quarter)	0.02M	0.01M	0.05M	0.02M	0.02M	0.03M	0.03M	0.03M	0.02M	0.02M	0.03M	0.02M	0.01M	0.01M	0.01M	0.00M	0.00M	0.00M	0.10M	0.00M
Income from Continuing Operations (Quarter)	3.44M	2.95M	7.57M	7.23M	3.45M	4.82M	6.01M	4.79M	4.86M	5.02M	2.77M	4.35M	3.31M	1.49M	0.63M	1.32M	1.14M	1.24M	23.15M	2.20M
Consolidated Net Income (Quarter)	-0.00M	0.15M	0.51M	7.23M	3.45M	4.82M	6.01M	4.79M	4.86M	5.02M	2.77M	4.35M	3.31M	1.49M	0.63M	1.32M	1.14M	1.24M	23.15M	2.20M
Income towards Parent Company (Quarter)	3.63M	3.14M	8.21M	7.30M	3.56M	4.82M	6.01M	4.88M	5.14M	5.04M	4.83M	3.78M	2.41M	0.66M	0.41M	0.45M	1.08M	1.30M	23.55M	0.09M
Net Income towards Common Stockholders (Quarter)	3.64M	3.15M	8.21M	7.30M	3.56M	4.82M	6.01M	4.88M	5.14M	5.04M	4.83M	3.78M	2.41M	0.66M	0.41M	0.45M	1.08M	1.30M	23.55M	0.09M
Additional items
EPS (Basic) (Quarter)	41.75	35.96	93.45	83.07	40.49	54.92	66.49	53.97	56.83	55.70	43.63	34.13	0.09	0.02	2.50	2.76	0.02	0.01	0.02	0.00
EPS (Diluted) (Quarter)	41.94	36.24	92.86	81.93	39.94	54.16	66.49	49.19	51.80	50.77	43.63	27.86	17.78	4.89	2.50	1.72	4.12	4.95	49.05	0.09
Shares Outstanding (Quarter)	0.09M	0.09M	0.09M	0.09M	0.09M	0.09M	0.09M	0.09M	0.09M	0.09M	0.11M	0.11M	27.53M	34.65M	0.16M	0.16M	54.72M	91.10M	960.11M	960.11M
Shares Outstanding (Diluted) (Quarter)	0.09M	0.09M	0.09M	0.09M	0.09M	0.09M	0.09M	0.10M	0.10M	0.10M	0.11M	0.14M	0.14M	0.14M	0.16M	0.26M	0.26M	0.26M	0.48M	0.93M
Shares Outstanding (Entity) (Quarter)	0.09M	0.09M	0.09M				0.09M				0.11M		27.53M	34.65M	0.16M		54.72M	91.10M	960.11M
EBITDA (Quarter)	3.62M	3.04M	7.78M	7.33M	3.59M	5.08M	6.60M	5.12M	5.13M	5.75M	6.27M	4.47M	3.46M	2.13M	1.02M	1.41M	1.24M	1.37M	23.45M	2.25M

Research Tools

Datasets

Plans

Developers

Purple Biotech PPBT Income Statement (2014-2026)

Research Tools

Datasets

Plans

Developers

Purple Biotech PPBT Income Statement (2014-2026)

Create an account

Sign In

Reset Password